CLRB
CELLECTAR BIOSCN (CLRB)
NASDAQ
$2.60-$0.004 (-0.15%)
Price as of Jun 03, 2026 7:41 PM EDT
  • $25.1M
    Market Cap
  • -81.23%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
N/A
0
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-11.5M
-56.00%
-26.1M
-4.14%
-27.3M
+41.87%
-19.2M
+9.29%
Depreciation and Amortization Expense
213,597
-26.76%
291,653
+51.61%
192,375
+29.60%
148,435
N/A
Total Operating Expenses
23.0M
-55.62%
51.8M
+32.90%
39.0M
+35.22%
28.8M
+19.40%
Operating Profit
-23.0M
-55.62%
-51.8M
+32.90%
-39.0M
+35.22%
-28.8M
+19.40%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
0
N/A
0
N/A
0
N/A
0
N/A
Total Nonoperating Income and Expense
1.2M
-83.63%
7.3M
+287.66%
-3.9M
-2,637.37%
152,519
+1,610.24%
Income before Taxes
-21.8M
-51.05%
-44.5M
+3.93%
-42.8M
+49.44%
-28.7M
+18.77%
Income Taxes
-6.8M
-10,384.85%
66,000
+210.00%
-60,000
0.00%
-60,000
-99.27%
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-21.8M
-51.12%
-44.6M
+4.23%
-42.8M
+49.54%
-28.6M
+18.57%
Net Income from Continuing Operations Applicable to Common
-21.8M
-51.05%
-44.5M
+3.93%
-42.8M
+49.44%
-28.7M
+18.82%
Basic EPS and Net Income
-8.35
+584.43%
-1.22
-65.14%
-3.50
-13.58%
-4.05
+841.86%
Diluted EPS and Net Income
-8.35
+496.43%
-1.40
-60.00%
-3.50
-13.58%
-4.05
+432.89%
Basic Weighted Average Shares
2.6M
-92.88%
36.6M
+199.65%
12.2M
+73.22%
7.1M
-87.29%
Diluted Weighted Average Shares
2.6M
-92.98%
37.1M
+203.92%
12.2M
+73.22%
7.1M
-87.29%
Balance Sheet
Cash and Cash Equivalents
13.2M
-43.34%
23.3M
+143.48%
9.6M
-51.85%
19.9M
-44.36%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
13.2M
-43.34%
23.3M
+143.48%
9.6M
-51.85%
19.9M
-44.36%
Total Current Assets
14.0M
-42.11%
24.3M
+131.99%
10.5M
-49.08%
20.5M
-43.86%
Accumulated Depreciation
1.2M
+15.82%
1.0M
+15.72%
884,909
+27.78%
692,534
+27.12%
Property and Plant and Equipment and Net
549,405
-27.43%
757,121
-30.56%
1.1M
+160.44%
418,641
+21.52%
Total Long-Term Assets
29,780
0.00%
29,780
0.00%
29,780
+379.24%
6,214
0.00%
Total Assets
15.0M
-41.20%
25.5M
+110.96%
12.1M
-44.07%
21.6M
-41.97%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
4.7M
-49.40%
9.4M
-62.98%
25.4M
+358.62%
5.5M
+38.57%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
309,397
-24.46%
409,586
-17.09%
494,003
-10.67%
552,981
+232.54%
Total Liabilities
5.1M
-48.36%
9.8M
-62.10%
25.9M
+325.05%
6.1M
+46.33%
Retained Earnings
-269.1M
+8.81%
-247.3M
+21.99%
-202.8M
+12.96%
-179.5M
+41.59%
Total Stockholders Equity
8.5M
-40.28%
14.3M
+194.30%
-15.2M
-197.75%
15.5M
-53.07%
Total Shares Outstanding
4.2M
-90.80%
46.1M
+122.13%
20.7M
+121.03%
9.4M
-84.64%
Cash Flow
Cash from Operating Activities
-23.1M
-51.41%
-47.6M
+46.97%
-32.4M
+28.37%
-25.2M
+11.76%
Capital Expenditures
5,880
-94.36%
104,195
-87.94%
864,038
+282.37%
225,971
+59.85%
Cash from Investing Activities
-5,880
-94.36%
-104,195
-87.94%
-864,038
+282.37%
-225,971
+59.85%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
13.0M
-78.78%
61.4M
+167.71%
22.9M
+138.69%
9.6M
+669.59%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-107.74%
-54.63%
-237.45%
-6.55%
-254.09%
+161.15%
-97.30%
+93.33%
Return on Equity
-190.88%
-101.85%
10,316.35%
+142.04%
-24,541.95%
+20,730.85%
-117.82%
+114.51%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
2.96
+14.42%
2.58
+526.69%
0.41
-88.90%
3.71
-59.49%
Cash Ratio
2.78
+12.00%
2.48
+557.66%
0.38
-89.50%
3.59
-59.85%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow